As of November 6, 2026, Talphera, Inc. is a publicly traded company (Nasdaq: TLPH). The largest holder reporting an active stake on Schedule 13D is CorMedix Inc., at 19.95%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Passive holders reporting on Schedule 13G include Rosalind Advisors, Inc. (9.9%), Orin Hirschman (9.8%), Rock Springs Capital Management LP (7.88%) (Schedule 13D, September 12, 2025).
Is this your company?
About to sign with, pay or invest in Talphera, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Talphera, Inc. a real, registered company?
- Talphera, Inc. files with the SEC under CIK 1427925 (its SEC filings).
- Its shares are listed under the ticker TLPH on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in San Mateo, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under TALPHERA, INC. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Rosalind Advisors, Inc. (filed 2026-08-12).
Who are Talphera, Inc.'s owners and officers?
Talphera, Inc.: incorporated in Delaware; business address in San Mateo, California; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-08-12).
Officers and directors, each with the role and the filing that names them:
- : Executive Officer, Director (Form D, 2025-09-15)
- : Executive Officer (Form D, 2025-09-15)
- : Executive Officer (Form D, 2025-09-15)
- : Director (Form D, 2025-09-15)
- : Executive Officer (Form D, 2025-09-15)
- : Director (Form D, 2025-09-15)
- : Director (Form D, 2025-09-15)
- : Director (Form D, 2025-09-15)
- : Director (Form D, 2025-09-15)
- : Director (Form D, 2025-09-15)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-08-12 | Rosalind Advisors, Inc. | 9.9% |
| Schedule 13G/A, 2026-05-15 | Lytton Laurence W | 2.5% |
| Schedule 13G/A, 2026-05-12 | Rosalind Advisors, Inc. | 9.9% |
| Schedule 13G/A, 2026-02-17 | Lytton Laurence W | 5.9% |
| Schedule 13G/A, 2026-02-11 | Rosalind Advisors, Inc. | 9.9% |
| Schedule 13G/A, 2026-01-30 | Orin Hirschman | 9.8% |
| Schedule 13G/A, 2025-11-13 | Rosalind Advisors, Inc. | 9.9% |
| Schedule 13G, 2025-11-10 | Orin Hirschman | 9.7% |
| Schedule 13G, 2025-09-16 | Lytton Laurence W | 8% |
| Schedule 13D, 2025-09-12 | Cormedix Inc. | 19.95% |
| Schedule 13G, 2025-09-12 | Rock Springs Capital Management LP | 7.88% |
Questions about who owns Talphera, Inc.
Who owns Talphera, Inc.?
On this page, 4 holders' latest ownership filings report 5% or more of Talphera, Inc.: Cormedix Inc. (19.95%, Schedule 13D, filed 2025-09-12), Rosalind Advisors, Inc. (9.9%, Schedule 13G/A, filed 2026-08-12), Orin Hirschman (9.8%, Schedule 13G/A, filed 2026-01-30) and Rock Springs Capital Management LP (7.88%, Schedule 13G, filed 2025-09-12).
Who are the largest shareholders of Talphera, Inc.?
By the share each holder's latest filing reports, the largest holders of Talphera, Inc. on this page are Cormedix Inc. (19.95%), Rosalind Advisors, Inc. (9.9%) and Orin Hirschman (9.8%).
When did Cormedix Inc. buy into Talphera, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Cormedix Inc. on this page is the Schedule 13D, filed 2025-09-12, reporting 19.95%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 11 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Talphera, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Talphera, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Talphera, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
21 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Talphera, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- CorMedix Inc., a 10% owner: 9,090,909 shares (17.5% of shares outstanding) (Form 3, 2025-09-12).
- , the chief executive and a director: 790,767 shares (1.5% of shares outstanding) (Form 4, 2026-04-03).
- , the chief financial officer: 85,879 shares (0.17% of shares outstanding) (Form 4, 2026-04-03).
- , the chief medical officer: 76,542 shares (0.15% of shares outstanding) (Form 4, 2026-05-21).
- , the chief engineering officer: 71,440 shares (0.14% of shares outstanding) (Form 4, 2026-04-03).
Shares outstanding: 51,905,796 as of 2026-08-06, from the company's latest SEC cover page.
How much has Talphera, Inc. raised?
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2025-09-15 | $16.98M | $28.97M |
| Form D, 2025-04-17 | $4.92M | $15M |
| Form D, 2024-01-29 | $6M | $6M |
| Form D, 2023-07-28 | $10M | $10M |
Keep reading
More on Talphera, Inc. and the records around it.
Talphera, Inc. elsewhere on the record
- 5%+ stake filings Aug 2026
- Form D filing Sep 2025
- Form D filing Apr 2025
Companies that share a holder
- Rock Springs Capital Management LP also filed stake reports on 1 other company: Spruce Biosciences, Inc. (Aug 2025)
- Rosalind Advisors, Inc. also filed stake reports on 11 other companies: DELCATH SYSTEMS, INC. (Oct 2026), FEMASYS INC (Aug 2026), FENNEC PHARMACEUTICALS INC. (Aug 2026)
- LYTTON LAURENCE W also filed stake reports on 28 other companies: Retension Pharmaceuticals, Inc. (Oct 2026), Rank One Computing Corp (Aug 2026), MDxHealth SA (Aug 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/talphera